Ana Blasco
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 15
- Cancer-related molecular mechanisms research 6
- Oncology top 5%
- Lung Cancer Research Studies 14
- Cancer Immunotherapy and Biomarkers 13
- Colorectal Cancer Treatments and Studies 5
-
- Lung Cancer Treatments and Mutations 31
- Lung Cancer Diagnosis and Treatment 9
- Complementary and Manual Therapy top 10%
-
- Genetic factors in colorectal cancer 6
- Co-authors
- Carlos CampsRafael SireraEloísa Jantus‐LewintreSilvia Calabuig‐FariñasR. GuijarroRoy M. BremnesRafael RosellJosé Javier Sánchez
- Journals
- Journal of Clinical Oncology (18 papers)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)
In The Last Decade
Ana Blasco
97 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 107
- Cancer Research 456
- Oncology 726
- Pulmonary and Respiratory Medicine 648
- Complementary and Manual Therapy 16
- Molecular Biology 487
Countries citing papers authored by Ana Blasco
This map shows the geographic impact of Ana Blasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Blasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Blasco more than expected).
Fields of papers citing papers by Ana Blasco
This network shows the impact of papers produced by Ana Blasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Blasco. The network helps show where Ana Blasco may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ana Blasco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 11 | |
| 5 | 2021 | 5 | |
| 6 | 2021 | 17 | |
| 7 | 2021 | 34 | |
| 8 | 2020 | 40 | |
| 9 | 2020 | 23 | |
| 10 | 2020 | 1 | |
| 11 | 2019 | 75 | |
| 12 | 2018 | 46 | |
| 13 | 2017 | 2 | |
| 14 | 2016 | 1 | |
| 15 | 2013 | 22 | |
| 16 | 2010 | 3 | |
| 17 | 2008 | 1 | |
| 18 | 2007 | 1 | |
| 19 | 2006 | 5 | |
| 20 | 2003 | 23 |
About Ana Blasco
Ana Blasco is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 104 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (31 papers), Cancer Genomics and Diagnostics (15 papers), Lung Cancer Research Studies (14 papers), Cancer Immunotherapy and Biomarkers (13 papers), Lung Cancer Diagnosis and Treatment (9 papers), Genetic factors in colorectal cancer (6 papers), Cancer-related molecular mechanisms research (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Cancer Research (456 citations), Oncology (726 citations) and Pulmonary and Respiratory Medicine (648 citations). Ana Blasco has collaborated with scholars based in Spain, Norway and France. Frequent co-authors include Carlos Camps, Rafael Sirera, Eloísa Jantus‐Lewintre, Silvia Calabuig‐Fariñas, R. Guijarro, Roy M. Bremnes, Rafael Rosell, José Javier Sánchez, Elena Sanmartín and Miguel Martorell. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.